Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Abstract

Genome-wide association studies (GWAS) in diverse populations are needed to reveal variants that are more common and/or limited to defined populations. We conducted a GWAS of breast cancer in women of African ancestry, with genotyping of >1,000,000 SNPs in 3,153 African American cases and 2,831 controls, and replication testing of the top 66 associations in an additional 3,607 breast cancer cases and 11,330 controls of African ancestry. Two of the 66 SNPs replicated (p < 0.05) in stage 2, which reached statistical significance levels of 10(-6) and 10(-5) in the stage 1 and 2 combined analysis (rs4322600 at chromosome 14q31: OR = 1.18, p = 4.3 × 10(-6); rs10510333 at chromosome 3p26: OR = 1.15, p = 1.5 × 10(-5)). These suggestive risk loci have not been identified in previous GWAS in other populations and will need to be examined in additional samples. Identification of novel risk variants for breast cancer in women of African ancestry will demand testing of a substantially larger set of markers from stage 1 in a larger replication sample.

Conflict of interest statement

Conflict of interest: The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
The distribution of observed versus expected -log10 p-values from stage 1 adjusted for age, study and the first principal component (PC1)
Fig. 2
Fig. 2
A Manhattan plot showing the -log10 p-values which test for case-control association to disease for genotyped and imputed SNPs by chromosome in stage 1

Similar articles

See all similar articles

Cited by 42 PubMed Central articles

See all "Cited by" articles

Publication types

Feedback